Innospec Inc. Expected to Earn Q4 2017 Earnings of $1.16 Per Share (NASDAQ:IOSP)
Innospec Inc. (NASDAQ:IOSP) – Equities researchers at KeyCorp increased their Q4 2017 EPS estimates for Innospec in a research note issued on Sunday. KeyCorp analyst M. Sison now anticipates that the specialty chemicals company will earn $1.16 per share for the quarter, up from their previous forecast of $1.06.
Other equities analysts have also recently issued research reports about the stock. Zacks Investment Research cut shares of Innospec from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, July 12th. BidaskClub cut shares of Innospec from a “hold” rating to a “sell” rating in a research note on Thursday, June 22nd.
Shares of Innospec (NASDAQ:IOSP) traded up 0.47% during mid-day trading on Wednesday, hitting $64.75. 17,283 shares of the stock traded hands. Innospec has a 1-year low of $49.32 and a 1-year high of $74.75. The company’s 50-day moving average price is $65.39 and its 200 day moving average price is $65.51. The company has a market capitalization of $1.56 billion, a PE ratio of 19.86 and a beta of 1.17.
Innospec (NASDAQ:IOSP) last announced its earnings results on Tuesday, May 9th. The specialty chemicals company reported $1.00 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.86 by $0.14. The company had revenue of $294.30 million during the quarter, compared to the consensus estimate of $287 million. Innospec had a net margin of 8.24% and a return on equity of 14.63%. The firm’s revenue for the quarter was up 38.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.93 earnings per share.
A number of institutional investors have recently bought and sold shares of IOSP. BlackRock Inc. boosted its position in Innospec by 29,556.5% in the first quarter. BlackRock Inc. now owns 2,971,282 shares of the specialty chemicals company’s stock valued at $192,389,000 after buying an additional 2,961,263 shares in the last quarter. Norges Bank acquired a new stake in Innospec during the fourth quarter valued at approximately $26,408,000. Lazard Asset Management LLC raised its stake in Innospec by 221.5% in the first quarter. Lazard Asset Management LLC now owns 529,340 shares of the specialty chemicals company’s stock valued at $34,274,000 after buying an additional 364,676 shares during the last quarter. Wells Fargo & Company MN raised its stake in Innospec by 24.1% in the first quarter. Wells Fargo & Company MN now owns 892,271 shares of the specialty chemicals company’s stock valued at $57,776,000 after buying an additional 173,286 shares during the last quarter. Finally, Teachers Advisors LLC raised its stake in Innospec by 371.2% in the fourth quarter. Teachers Advisors LLC now owns 193,724 shares of the specialty chemicals company’s stock valued at $13,270,000 after buying an additional 152,609 shares during the last quarter. Institutional investors and hedge funds own 90.38% of the company’s stock.
Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.
Receive News & Ratings for Innospec Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec Inc. and related companies with MarketBeat.com's FREE daily email newsletter.